Lore Merdrignac, Fatima Aït El Belghiti, Elisabetta Pandolfi, Lesly Acosta, Kateřina Fabiánová, Adele Habington, Manuel García Cenoz, Håkon Bøås, Julie Toubiana, Alberto E Tozzi, Iolanda Jordan, Jana Zavadilová, Niam O'Sullivan, Ana Navascués, Elmira Flem, Ilena Croci, Mireia Jané, Pavla Křížová, Suzanne Cotter, Leticia Fernandino, Terese Bekkevold, Carmen Muñoz-Almagro, Sabrina Bacci, Piotr Kramarz, Esther Kissling, Camelia Savulescu
BACKGROUND: Monitoring effectiveness of pertussis vaccines is necessary to adapt vaccination strategies. PERTINENT, Pertussis in Infants European Network, is an active sentinel surveillance system implemented in 35 hospitals across six EU/EEA countries. We aim to measure pertussis vaccines effectiveness (VE) by dose against hospitalisation in infants aged <1 year. METHODS: From December 2015 to December 2019, participating hospitals recruited all infants with pertussis-like symptoms...
March 11, 2024: Vaccine